ANIP Similar Chart Price Prediction
The price of ANIP is predicted to go up 0.61%, based on the high correlation periods with RMNI. The similarity of these two price pattern on the periods is 91.3%.
ANIP
RMNI
Up: 0.61%Similarity: 91.3%
ANIP Revenue Forecast
ANIP EPS Forecast
ANIP FAQs
What is ANIP revenue forecast for next quarter？
What is ANIP eps forecast for next quarter？
ANIP Analyst's Forecast
Ekaterina Knyazkova
JP Morgan
Buy
2025-03-12
Price Target
$85
Upside
+34.37%
JPMorgan initiated coverage of ANI Pharmaceuticals with an Overweight rating and $85 price target. ANI is a specialty pharmaceuticals company with a "well-positioned and durable" portfolio of branded and generic products, the analyst tells investors in a research note. The firm sees a "long runway for growth" for Cortrophin Gel, the company's lead product, with room for additional uptake in ophthalmology, which JPMorgan says is benefiting from an increased commercial footprint, and other indications, including acute gouty arthritis. The analyst believes ANI will generate sales and earnings growth well ahead of its peers.
Vamil Divan
Guggenheim
Strong Buy
2025-03-05
Price Target
$84 → $86
Upside
+44.17%
Faisal Khurshid
Leerink Partners
Buy
2024-12-11
Price Target
$80
Upside
+35.51%
